114 related articles for article (PubMed ID: 37462216)
1. Piperazin incorporated Schiff Base derivatives: Assessment of in vitro biological activities, metabolic enzyme inhibition properties, and molecular docking calculations.
Mermer A; Tüzün B; Daştan SD; Koçyiğit ÜM; Çetin FN; Çevik Ö
J Biochem Mol Toxicol; 2023 Nov; 37(11):e23465. PubMed ID: 37462216
[TBL] [Abstract][Full Text] [Related]
2. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
4. Investigation of
Camadan Y; Çiçek B; Adem Ş; Çalişir Ü; Akkemik E
J Biomol Struct Dyn; 2022 Sep; 40(15):6965-6973. PubMed ID: 33645441
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors.
Buza A; Türkeş C; Arslan M; Demir Y; Dincer B; Nixha AR; Beydemir Ş
Int J Biol Macromol; 2023 Jun; 239():124232. PubMed ID: 37001773
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization, and biological studies of chalcone derivatives containing Schiff bases: Synthetic derivatives for the treatment of epilepsy and Alzheimer's disease.
Koçyiğit ÜM; Gezegen H; Taslimi P
Arch Pharm (Weinheim); 2020 Dec; 353(12):e2000202. PubMed ID: 32815568
[TBL] [Abstract][Full Text] [Related]
7. Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif.
Demir Y; Türkeş C; Çavuş MS; Erdoğan M; Muğlu H; Yakan H; Beydemir Ş
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200554. PubMed ID: 36575148
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, molecular docking analysis and carbonic anhydrase I-II inhibitory evaluation of new sulfonamide derivatives.
Sağlık BN; Çevik UA; Osmaniye D; Levent S; Çavuşoğlu BK; Demir Y; Ilgın S; Özkay Y; Koparal AS; Beydemir Ş; Kaplancıklı ZA
Bioorg Chem; 2019 Oct; 91():103153. PubMed ID: 31382057
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, characterization, enzymatic inhibition evaluations, and docking study of novel quinazolinone derivatives.
Pedrood K; Sherafati M; Mohammadi-Khanaposhtani M; Asgari MS; Hosseini S; Rastegar H; Larijani B; Mahdavi M; Taslimi P; Erden Y; Günay S; Gulçin İ
Int J Biol Macromol; 2021 Feb; 170():1-12. PubMed ID: 33352155
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of some thiophene-based sulfonamides as potent inhibitors of carbonic anhydrase I and II isoenzymes isolated from human erythrocytes by kinetic and molecular modelling studies.
Alım Z; Köksal Z; Karaman M
Pharmacol Rep; 2020 Dec; 72(6):1738-1748. PubMed ID: 32748253
[TBL] [Abstract][Full Text] [Related]
11. Novel propanolamine derivatives attached to 2-metoxifenol moiety: Synthesis, characterization, biological properties, and molecular docking studies.
Genc Bilgicli H; Ergon D; Taslimi P; Tüzün B; Akyazı Kuru İ; Zengin M; Gülçin İ
Bioorg Chem; 2020 Aug; 101():103969. PubMed ID: 32474181
[TBL] [Abstract][Full Text] [Related]
12. Quinoline-based promising anticancer and antibacterial agents, and some metabolic enzyme inhibitors.
Ökten S; Aydın A; Koçyiğit ÜM; Çakmak O; Erkan S; Andac CA; Taslimi P; Gülçin İ
Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000086. PubMed ID: 32537757
[TBL] [Abstract][Full Text] [Related]
13. Schiff bases and their amines: Synthesis and discovery of carbonic anhydrase and acetylcholinesterase enzymes inhibitors.
Yiğit B; Yiğit M; Taslimi P; Gök Y; Gülçin İ
Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800146. PubMed ID: 30033646
[TBL] [Abstract][Full Text] [Related]
14.
Korkmaz IN; Güller P; Kalın R; Öztekin A; Özdemir H
Curr Comput Aided Drug Des; 2022; 18(5):381-392. PubMed ID: 35984020
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of chalcone-imide derivatives and investigation of their anticancer and antimicrobial activities, carbonic anhydrase and acetylcholinesterase enzymes inhibition profiles.
Kocyigit UM; Budak Y; Gürdere MB; Ertürk F; Yencilek B; Taslimi P; Gülçin İ; Ceylan M
Arch Physiol Biochem; 2018 Feb; 124(1):61-68. PubMed ID: 28792233
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and molecular modelling studies of some pyrazole derivatives as carbonic anhydrase inhibitors.
Dizdaroglu Y; Albay C; Arslan T; Ece A; Turkoglu EA; Efe A; Senturk M; Supuran CT; Ekinci D
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):289-297. PubMed ID: 31797703
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors.
Akocak S; Lolak N; Nocentini A; Karakoc G; Tufan A; Supuran CT
Bioorg Med Chem; 2017 Jun; 25(12):3093-3097. PubMed ID: 28400084
[TBL] [Abstract][Full Text] [Related]
18. Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation.
Said MA; Eldehna WM; Nocentini A; Fahim SH; Bonardi A; Elgazar AA; Kryštof V; Soliman DH; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
Eur J Med Chem; 2020 Mar; 189():112019. PubMed ID: 31972394
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, molecular docking and biological activities of novel pyrazoline derivatives.
Turkan F; Cetin A; Taslimi P; Karaman HS; Gulçin İ
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800359. PubMed ID: 31125504
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Molecular Docking of New N-Acyl Hydrazones- Benzimidazole as hCA I and II Inhibitors.
Küçükoğlu K; Çevik UA; Nadaroglu H; Celik I; Işık A; Bostancı HE; Özkay Y; Kaplancıklı ZA
Med Chem; 2023; 19(5):485-494. PubMed ID: 36567289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
